Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 10

1.

Donepezil delays progression to AD in MCI subjects with depressive symptoms.

Lu PH, Edland SD, Teng E, Tingus K, Petersen RC, Cummings JL; Alzheimer's Disease Cooperative Study Group.

Neurology. 2009 Jun 16;72(24):2115-21. doi: 10.1212/WNL.0b013e3181aa52d3.

2.

Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial.

Sevigny JJ, Ryan JM, van Dyck CH, Peng Y, Lines CR, Nessly ML; MK-677 Protocol 30 Study Group.

Neurology. 2008 Nov 18;71(21):1702-8. doi: 10.1212/01.wnl.0000335163.88054.e7.

PMID:
19015485
3.
4.

A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.

Feighner JP, Boyer WF, Merideth CH, Hendrickson GG.

Int Clin Psychopharmacol. 1989 Apr;4(2):127-34.

PMID:
2663975
5.
6.

Multicenter placebo-controlled evaluation of nomifensine treatment in depressed outpatients.

Feighner JP, Merideth CH, Claghorn JL.

J Clin Psychiatry. 1984 Apr;45(4 Pt 2):47-51.

PMID:
6370974
7.

The use of bupropion in hospitalized depressed patients.

Merideth CH, Feighner JP.

J Clin Psychiatry. 1983 May;44(5 Pt 2):85-7.

PMID:
6406471
8.

A double-blind comparative trial with mianserin and amitriptyline in outpatients with major depressive disorders.

Feighner JP, Jacobs RS, Jackson RE, Hendrickson G, Merideth CH, O'Meara PD.

Br J Clin Pharmacol. 1983;15 Suppl 2:227S-237S.

9.
10.

A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.

Feighner JP, Merideth CH, Hendrickson GA.

J Clin Psychiatry. 1982 Dec;43(12 Pt 2):103-8.

PMID:
6130066
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk